We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.50 | 0.34% | 1,646.00 | 1,646.00 | 1,646.50 | 1,647.50 | 1,634.00 | 1,638.50 | 1,363,451 | 15:30:49 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.70 | 67.52B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 0616C
GlaxoSmithKline PLC
16 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Ms E Walmsley
=== ====================== =================================
b) Position/status Chief Executive Officer
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 87.861
----------- ----------
GBP13.306 87.861
----------- ----------
GBP13.306 217.580
----------- ----------
GBP13.306 217.564
----------- ----------
GBP13.306 236.894
----------- ----------
GBP13.306 236.879
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
1,084.639
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr R G Connor
=== ====================== =================================
b) Position/status President, Global Manufacturing
& Supply
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 64.344
----------- ----------
GBP13.306 64.344
----------- ----------
GBP13.306 147.828
----------- ----------
GBP13.306 123.348
----------- ----------
GBP13.306 123.334
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
523.198
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr L Debruyne
=== ====================== =================================
b) Position/status President, Global Vaccines
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 207.321
----------- ----------
GBP13.306 207.306
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
414.627
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr S Dingemans
=== ====================== =================================
b) Position/status Chief Financial Officer
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 122.724
----------- ----------
GBP13.306 122.707
----------- ----------
GBP13.306 287.332
----------- ----------
GBP13.306 287.316
----------- ----------
GBP13.306 215.211
----------- ----------
GBP13.306 215.211
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
1,250.501
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr N Hirons
=== ====================== =================================
b) Position/status SVP, Global Ethics & Compliance
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 45.052
----------- ----------
GBP13.306 45.052
----------- ----------
GBP13.306 106.239
----------- ----------
GBP13.306 106.239
----------- ----------
GBP13.306 77.966
----------- ----------
GBP13.306 77.951
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
458.499
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr B McNamara
=== ====================== ===================================
b) Position/status CEO, GSK Consumer Healthcare
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018 on ADSs held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$36.84 87.876
--------- ----------
=== ====================== ===================================
d) Aggregated
information
Aggregated
volume Price
87.876
$36.84
=== ====================== ===================================
e) Date of the 2018-01-11
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr D S Redfern
=== ====================== =================================
b) Position/status Chief Strategy Officer
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 72.194
----------- ----------
GBP13.306 72.194
----------- ----------
GBP13.306 135.207
----------- ----------
GBP13.306 135.207
----------- ----------
GBP13.306 98.121
----------- ----------
GBP13.306 98.106
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
611.029
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Ms C Thomas
=== ====================== =================================
b) Position/status SVP, Human Resources
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 97.174
----------- ----------
GBP13.306 97.158
----------- ----------
GBP13.306 197.805
----------- ----------
GBP13.306 197.805
----------- ----------
GBP13.306 147.686
----------- ----------
GBP13.306 147.686
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
885.314
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr P C Thomson
=== ====================== =================================
b) Position/status President, Global Affairs
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 66.002
----------- ----------
GBP13.306 121.024
----------- ----------
GBP13.306 92.975
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
280.001
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr D E Troy
=== ====================== ===================================
b) Position/status SVP & General Counsel
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018 on ADSs held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$36.84 50.006
--------- ----------
$36.84 50.006
--------- ----------
$36.84 112.593
--------- ----------
$36.84 112.593
--------- ----------
$36.84 93.253
--------- ----------
$36.84 93.239
--------- ----------
=== ====================== ===================================
d) Aggregated
information
Aggregated
volume Price
511.690
$36.84
=== ====================== ===================================
e) Date of the 2018-01-11
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Dr P J T Vallance
=== ====================== =================================
b) Position/status President, R&D
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018 on Ordinary
Shares held in the Company's
2009 Deferred Annual Bonus Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------
GBP13.306 143.039
----------- ----------
GBP13.306 143.039
----------- ----------
GBP13.306 232.681
----------- ----------
GBP13.306 232.681
----------- ----------
GBP13.306 160.411
----------- ----------
GBP13.306 160.411
----------- ----------
=== ====================== =================================
d) Aggregated
information
Aggregated
volume Price
1,072.262
GBP13.306
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDQLFFVFFZBBD
(END) Dow Jones Newswires
January 16, 2018 12:48 ET (17:48 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
